Phreesia (NYSE:PHR – Get Free Report) and Zepp Health (NYSE:ZEPP – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings.
Analyst Ratings
This is a summary of current ratings for Phreesia and Zepp Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Phreesia | 1 | 9 | 9 | 0 | 2.42 |
| Zepp Health | 1 | 0 | 1 | 0 | 2.00 |
Phreesia presently has a consensus price target of $16.65, suggesting a potential upside of 81.50%. Zepp Health has a consensus price target of $56.28, suggesting a potential upside of 1,016.22%. Given Zepp Health’s higher possible upside, analysts clearly believe Zepp Health is more favorable than Phreesia.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Phreesia | 1.85% | 5.13% | 3.12% |
| Zepp Health | -14.70% | -15.64% | -6.03% |
Insider and Institutional Ownership
92.1% of Phreesia shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Phreesia and Zepp Health”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Phreesia | $480.59 million | 1.18 | $2.31 million | $0.15 | 61.15 |
| Zepp Health | $258.90 million | 0.29 | -$40.07 million | ($2.52) | -2.00 |
Phreesia has higher revenue and earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Phreesia has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Zepp Health has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500.
Summary
Phreesia beats Zepp Health on 11 of the 14 factors compared between the two stocks.
About Phreesia
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
About Zepp Health
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
